- Home
- UAL vs BNTX Comparison
UAL vs BNTX Comparison
Compare UAL & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | UAL | BNTX |
|---|---|---|
| Founded | 1934 | 2008 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Air Freight/Delivery Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 34.6B | 24.8B |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | UAL | BNTX |
|---|---|---|
| Price | $112.65 | $92.25 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 14 | 11 |
| Target Price | $128.31 | ★ $137.40 |
| AVG Volume (30 Days) | ★ 5.8M | 1.4M |
| Earning Date | 01-20-2026 | 11-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.30 | N/A |
| EPS | ★ 9.99 | N/A |
| Revenue | ★ $58,369,000,000.00 | $3,698,814,972.00 |
| Revenue This Year | $4.70 | $2.36 |
| Revenue Next Year | $7.65 | N/A |
| P/E Ratio | $11.26 | ★ N/A |
| Revenue Growth | ★ 4.24 | 3.70 |
| 52 Week Low | $52.00 | $81.20 |
| 52 Week High | $116.00 | $129.27 |
Technical Indicators
Market Signals| Indicator | UAL | BNTX |
|---|---|---|
| Relative Strength Index (RSI) | 67.53 | 33.03 |
| Support Level | $106.28 | $91.40 |
| Resistance Level | $109.62 | $97.35 |
| Average True Range (ATR) | 3.31 | 2.27 |
| MACD | 0.87 | -0.39 |
| Stochastic Oscillator | 84.84 | 5.61 |
Price Performance
Historical ComparisonAbout UAL United Airlines Holdings Inc.
Chicago-based United Airlines is a major US network carrier with hubs in San Francisco, Chicago, Houston, Denver, Los Angeles, Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international and long-haul travel, especially across the Pacific, than its large US peers.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. Comirnaty, its Pfizer-partnered covid vaccine, is its first commercialized product.